BIRC5 and pachyonychia congenita: RNA-Seq analysis of survivin (BIRC5) mRNA expression levels in datasets of benign prostate, localized PC, CRPC, and NEPC tissue samples [33,34] showed no significant difference between benign tissue and PC.